Over $2 million, the most expensive medicine to cure baby disease

The U.S. regulator approved the most expensive drug ever for a successive disease that destroys muscle control in young children. Children affected die within a few months. Treatment costs $2.125 million. Costs out of pocket for patients will vary depending on insurance. The medicine, sold by a Swedish, [...]
Treatment costs $2.125 million. Costs out of pocket for patients will vary depending on insurance.
The medicine, sold by a Swedish, Novatitis, is a gene therapy that treats an inherited state of muscular atrophysis.
Treatment targets a defective gene that weakens children's muscles so much that they are no longer able to move up to the inability to swallow and breathe. This disease strikes 400 children in America every year
The management of medicine and health yesterday approved treatment with medicine called Zolgesma, for children under 2 years of age and health, approved yesterday treatment with medicine called Zolgesma, for children under the age of 2 who through the genetic test were confirmed to have one of the three types of this disease. Therapy is taken through serum in an hour.
Novattis says he allows drug users to pay in five years, $45,000 a year, and if the therapy doesn't work then all the money is returned, we wrote AP.












